The end-stage liver disease requires liver transplantation as a therapy option. Living donor liver transplant (LDLT) has emerged as a clinically safe alternative to deceased donor liver transplants, thanks to advances in surgical methods and the advent of new immunosuppressive drugs. It was first presented in 1989 for children, and it was gradually embraced by adults ten years later.
It has become the "first approach" in liver transplant situations as it not only addresses donor scarcity but also rapidly expands the donor pool. In this regard, we bring to you an exclusive Docplexus Surgical Suite session with Dr. Gaurav Gupta , where he will discuss Living Donor Liver Transplant on 4th December, 5:00 PM onwards.
